Communiqués

18/09/23 M2Bio Sciences Pharmacology and Clinical Application of CBD AQ
19/07/23 MRES: M2Bio Sciences Appoints Adrian J. Maizey, Accomplished CEO and Financial Expert, to Advisory Board AQ
19/07/23 CapitalGainsReport Penny Stocks With News Making Moves (DDDX, MRES, GEGI, CYXTQ) AQ
17/07/23 MRES: M2Bio Sciences Unveils an Exciting Line of Purple, White, and Green Teas from Kenya, Exhibiting Numerous Medicinal Health Benefits AQ
06/07/23 MRES: M2Bio Sciences Unveils Explainer Video Showcasing Groundbreaking NFTs and Altcoins for Drug Discovery, Revolutionizing Investment Access PR
05/07/23 MRES: Institute of Biomedical Research Announces Application for Name Change and New Ticker Symbol in Anticipation of Future M&A Activities and Senior Listing PR
27/06/23 MRES: M2Bio Sciences Enters into Letter of Intent to Acquire Crypto Exchange JDAX PR
16/06/23 MRES: M2Bio Sciences Establishes Research Chair at The University of Pretoria for Phytomedicines PR
14/06/23 MRES: M2Enviro Expands R&D Efforts to Explore Diverse Classes of Mycelium Composite Materials for Commercialization PR
07/06/23 MRES: Institute of Biomedical Research unveils artificial intelligence (AI) powered initiatives within its CBD product range, psilocybin research, and cardiometabolic health solutions PR
25/05/23 M2Bio Sciences Division M2Biome Cardiometabolic Health Launches Website AQ
14/09/22 As monkeypox drops in the West, still no vaccines for Africa AQ
02/08/22 Institute of Biomedical Research : Attorney Letter with Respect to Annual Report Period Ending March 31 2022 PU
22/07/22 Institute of Biomedical Research Corp Announces Purchase of Biomedical and Nutraceutical Assets AQ
27/01/15 INSE BIOM : The Institute of Biomedical Research Corp. : Announces New Corporate Direction in Acquisition of TRAVEL MIX GROUP MW
Aucun résultat pour cette recherche
DERNIÈRES HEURES | -40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT